BCL11A and Schnyder corneal dystrophy: Our results indicate a high level of diverse LDs of up to 3527 bp at the BCL11A enhancer region in SCD HSPCs (Fig. 4F), which could inactivate BCL11A, leading to an adverse effect on HSC function and significantly reducing the engraftment potential (36).